For both sides

Buying or selling a cannabis business in Utah

Federal and state law current as of September 2026 — verify with counsel.

Utah licenses medical cannabis only. Fifteen medical cannabis pharmacies operate statewide, with two additional independent rural licences created by 2025 legislation, so entry is by acquisition. Regulation moves from the Department of Health and Human Services to the Department of Agriculture and Food by 1 January 2027. Because the market is medical-only, Utah licensees sit outside federal 280E going forward.

Key takeaways

  • Utah had 15 licensed medical cannabis pharmacies and 107,890 active cardholders at the end of 2025, with about $16 million of pharmacy sales in December 2025 alone.
  • HB 54 of 2025 created two independent medical cannabis pharmacy licences for medically underserved areas in third- through sixth-class counties; the second application window ran 3 August to 2 September 2026, with the licence to be issued by 1 January 2027.
  • An independent pharmacy licensee may not own an interest in another medical cannabis pharmacy, nor be owned by an entity with an interest in a cannabis production establishment.
  • A medical cannabis pharmacy must report a change of ownership in writing at least 10 business days in advance, and a change of 50% or more requires an application, department approval, and a fee.
  • HB 389 and SB 121 of 2026 move the programme from DHHS to UDAF by 1 January 2027, with the handover able to start from 1 July 2026.

Utah licenses medical cannabis only, under the Utah Medical Cannabis Act passed in 2018 after Proposition 2. There is no adult-use market and no prospect of one on the current legislative record.

Two agencies share the programme today. The Center for Medical Cannabis at the Department of Health and Human Services handles patients, medical providers, and pharmacies. The Department of Agriculture and Food regulates cultivators, processors, pharmacies, and couriers for product safety and compliance.

That split is ending. HB 389 and SB 121 of the 2026 session, effective 6 May 2026, move DHHS duties to UDAF by 1 January 2027, with the transfer able to begin from 1 July 2026. Anyone planning a Utah transaction across that window should confirm which agency owns the file.

Are Utah licences capped?

Yes, tightly. Utah is one of the most restricted limited-licence states in the country. Fifteen medical cannabis pharmacies were operating at the end of 2025.

HB 54 of 2025 added two independent pharmacy licences aimed at medically underserved areas in third-, fourth-, fifth-, or sixth-class counties. UDAF ran the application window for the second of them from 3 August to 2 September 2026, with the licence required to be issued by 1 January 2027. After that, Utah’s retail map is effectively closed again.

The independence condition on those two licences matters commercially: the holder may not own a financial interest in another medical cannabis pharmacy, and may not be owned by an entity that owns an interest in or operates a cannabis production establishment. In plain terms, they cannot be rolled into a vertically integrated group. Check which category a target falls into before you model a consolidation.

Cultivation and processing are similarly closed. UDAF publishes the current licensees through its licence lookup rather than running open rounds.

How a sale works in Utah

Utah uses ownership-change approval on the existing licensee. Two thresholds drive the timetable.

  1. Notification. A medical cannabis pharmacy must report a change of ownership in writing to the department no later than 10 business days before the change takes effect.
  2. Approval. A change of ownership interest of 50% or more requires an application, department approval, and payment of a fee. The application package includes how the pharmacy will keep meeting minimum standards, and the results of any formal investigation, charge, claim, or adverse action against the incoming owners over the previous seven years.

The department may also charge a fee for a change of location or company structure. Because the seven-year adverse-action disclosure reaches beyond cannabis, buyers with any regulatory history in other industries should surface it early rather than have it found. General framework is in change of ownership approval explained, and the drafting response is in regulatory-approval contingencies.

Taxes and 280E

Utah does not impose a percentage cannabis excise tax of the kind adult-use states use. Patients pay a state fee on each purchase, and the 2026 legislation allows UDAF to increase it. Confirm current sales tax treatment with the State Tax Commission for the specific product mix.

The bigger tax story is federal. The Federal Register order of 28 April 2026 placed marijuana subject to a state medical marijuana licence into Schedule III. Section 280E only disallows deductions for trafficking in Schedule I and II substances. Utah’s licensed market is entirely medical, so Utah operators have no adult-use activity to apportion, unlike dual operators in Arizona or Nevada. That is a genuine structural advantage, and it changes the arithmetic a buyer runs. See 280E explained for buyers and sellers and rescheduling tax scenarios.

Do not overstate it. No final rule on broader rescheduling had issued as of mid-September 2026, and the transition mechanics, including how prior-year positions are treated, were still unsettled. Model the benefit, do not assume a refund.

Market conditions in 2026

Utah is small, growing, and supply-constrained — the opposite of most western markets.

Compare that with Colorado and Oregon, where sales are falling and licence counts are shrinking. Utah has the rarer combination of rising patient numbers and a fixed number of retail doors.

What this means for sellers

Utah pharmacies rarely trade, and when they do the licence carries a real scarcity premium on top of earnings, because no one can apply for another one. The buyer pool is narrow: existing Utah licensees, well-capitalised groups that can clear the seven-year disclosure, and, for the independent rural licences, only parties with no other pharmacy or production interests. Expect a longer, quieter search than in an open market, and read selling a licence in a limited-licence state.

What this means for buyers

Price the scarcity, but test the demand. A Utah pharmacy’s revenue is bounded by cardholder counts in its catchment and by product available from a closed set of cultivators. Confirm the licence category, because the independence condition on the two rural licences forecloses the consolidation thesis that usually justifies a premium. Confirm which agency will process your ownership change across the 2027 handover. And run the earnings without 280E, which is the correct way to value a medical-only operator now, rather than applying an adult-use market’s effective tax rate. A 20-minute intro call can work through whether an approach to a Utah licensee is realistic.

Is a broker licence required?

Trade sources list Utah among the states reported to require a real estate licence for business brokerage in at least some transactions, which usually turns on whether real property is included. See business broker licensing by state.

This page is educational and is not legal or tax advice.

Frequently asked questions

Is there an adult-use cannabis market in Utah?

No. Utah licenses medical cannabis only, under the Utah Medical Cannabis Act. There is no adult-use retail, no consumption lounge licence, and no open cultivation market. Everything that can be bought or sold as a licensed cannabis business in Utah is inside the medical programme, which is why licences change hands so rarely here.

How does the move from DHHS to UDAF affect a deal in progress?

It changes who processes your file. The 2026 legislation transfers programme duties to the Department of Agriculture and Food by 1 January 2027, with the handover able to begin from 1 July 2026. Confirm which agency holds the licence file and the ownership-change queue before you commit to a closing date, and build schedule flexibility into the agreement.

Does 280E still apply to a Utah medical cannabis business?

Not to state-licensed medical activity going forward. The April 2026 federal order placed marijuana subject to a state medical marijuana licence in Schedule III, and 280E only reaches Schedule I and II substances. Because Utah has no adult-use market, Utah licensees have no adult-use activity to apportion, which makes their earnings unusually clean compared with dual-market states.

Can an out-of-state operator buy into a Utah pharmacy?

It depends on the licence. The two independent rural pharmacy licences carry a structural restriction: the holder may not own an interest in another pharmacy or be owned by an entity with an interest in a cannabis production establishment. That rules out most multi-state operators for those two licences. The other pharmacies are not subject to the same independence condition.

How big is the Utah patient market?

There were 107,890 active cardholders at the end of 2025, and pharmacy sales ran at about $16 million a month by December 2025. A 2026 voucher programme gives eligible Medicaid and Medicare cardholders $150 a month toward purchases, which is a demand tailwind a buyer can reasonably model.

Sources

  1. Utah Department of Health and Human Services, Center for Medical Cannabis — 2026 medical cannabis law updates — https://medicalcannabis.utah.gov/resources/utah-medical-cannabis-law/2026-utah-medical-cannabis-law-updates/
  2. Utah Department of Agriculture and Food — UDAF opens application to license new independent medical cannabis pharmacy — https://ag.utah.gov/news/udaf-opens-application-to-license-new-independent-medical-cannabis-pharmacy/
  3. Utah Department of Agriculture and Food — Medical cannabis programme — https://ag.utah.gov/farmers/regulatory-services-division/industrial-hemp-program/medical-cannabis/
  4. Utah Department of Health and Human Services — Center for Medical Cannabis Annual Report 2025 — https://medicalcannabis.utah.gov/wp-content/uploads/DHHS_CMC-Annual-Report_2025.pdf
  5. Utah Department of Health and Human Services, Center for Medical Cannabis — Monthly Report, December 2025 — https://medicalcannabis.utah.gov/wp-content/uploads/2025-12-Monthly-Report.pdf
  6. Federal Register — Schedule III placement of FDA-approved and state-medical-licensed marijuana, 2026-08176 (28 April 2026) — https://www.federalregister.gov/d/2026-08176
  7. Cornell LII — 26 U.S. Code 280E — https://www.law.cornell.edu/uscode/text/26/280E